Will GW’s multibillion-dollar sale ‘open floodgates’ to pharma-cannabis deal-making?
Jazz Pharmaceuticals’ planned $7.2 billion takeover of United Kingdom-based GW Pharmaceuticals could kick off a wave of deal-making between pharma and medical […]
Jazz Pharmaceuticals’ planned $7.2 billion takeover of United Kingdom-based GW Pharmaceuticals could kick off a wave of deal-making between pharma and medical […]
Medical cannabis products in Canada should be dispensed to patients inside pharmacies – a natural progression for the sector that would lead […]
Nearly 40% of Newfoundland and Labrador’s licensed cannabis retailers have been shut down as the result of a labor action that appears […]